We,re talking about an IND. Come on, they didn't deny it when it was first submitted, why would they request more info and create more work for them. They know this has the potential to become a novel treatment for a unmet medical need. For new comers... PSTI got FDA approved and orphan status for same disease as bmsn... In the bag imo
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.